ABOUT CANOPY GROWTH
Headquarters: Smiths Falls, Ont.
In business since: 2014 Employees: 1,800 Revenue: $40-million in 2017
Marijuana companies tend to elicit jokes about high profit margins. But at Canopy Growth Corp., cannabis is a serious, science-based business, its chief says. North America’s first publicly traded cannabis company – and Canada’s largest medical marijuana producer – has built a credible enterprise by focusing on consistency in its products and strict adherence to scientific protocols.
In addition to its first-to-thes-tock-exchange status, the company boasts other firsts in its industry, says Bruce Linton, founder and co-CEO of Canopy, which has two divisions, medical and recreational, with businesses spanning from greenhouses and manufacturing to online and bricks-and-mortar retail.
The company has grown its footprint and diversified its operations through internal expansion and partnerships with other industry players.
Canopy recently became first to legally export cannabis to the United States, where it will be used for medical research, says Mr. Linton. Canopy is also an active educator, offering programs to Canadian doctors.
With recreational marijuana soon to be legal in Canada, Canopy is positioned to become the dominant player in the cannabis industry, says Mr. Linton. The firm offers a range of brands and cannabis strains in various forms that include dried, oil and soft-gel capsules.